The epidemiology of generalized anxiety disorder

Psychiatric Clinics of North America

Volumn 24, Issue 1, 2001, Pages 19-39

  Kessler, Ronald C ^a   Keller, Martin B ^b   Wittchen, Hans Ulrich ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANXIETY NEUROSIS; CHILD; COMORBIDITY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MENTAL DISEASE; MOOD; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

EID: 0035125915     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70204-5     Document Type: Article

References (70)

1. Anxiety: Definition, relationship to depression, and proposal for an integrative model
2. Toward a clinical understanding of the relationship of anxiety and depressive disorders
3. The natural history of anxiety disorder and generalized anxiety disorder
4. Generalized anxiety and generalized anxiety disorder: Description and reconceptualization
5. The prevalence of psychiatric disorders in primary care practice
6. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
7. Personality disorder traits in generalized anxiety and panic disorder patients
8. Generalized anxiety disorder
9. Generalized anxiety disorder: Issues in epidemiology
10. Psychiatric comorbidity in patients with generalized anxiety disorder
11. The diagnostic validity of anxiety disorders and their relationship to depressive illness
12. Depressive symptoms, major depression and generalized anxiety: A comparison of self-reports on CES-D and results from diagnostic interviews
13. DSM-III generalized anxiety disorder: An empirical investigation of more stringent criteria
14. Further evidence on the doubtful validity of generalized anxiety disorder
15. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal
16. Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five U.S. community populations
17. Follow-up and family study of anxious depression
18. The empirical structure of psychiatric comorbidity and its theoretical significance
19. On predicting improvement and relapse in generalized anxiety disorder following psychotherapy
20. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996
21. Comorbid depression and anxiety spectrum disorders
22. Venlofaxine XR in the treatment of anxiety
23. Evidence for genetic influences on personality from self-reports and informant ratings
24. Generalized anxiety disorder with early and late onset of anxiety symptoms
25. Cross-national comparisons of the prevalences and correlates of mental disorders. An ICPE study
26. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs
27. Generalized anxiety disorder in women: A population based twin study
28. Major depression and generalized anxiety disorder: Same genes, (partly) different environments?
29. The epidemiology of psychiatric comorbidity
30. The prevalence of psychiatric comorbidity
31. The epidemiology of pure and comorbid generalized anxiety disorder: A review and evaluation of recent research
32. Impairments of twelve-month independent and comorbid generalized anxiety disorder and major depression in two national surveys
33. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
34. The effects of chronic medical conditions on work impairment
35. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
36. Primary prevention of secondary disorders: A proposal and agenda
37. Frustrating patients: Physician and patient perspectives among distressed high users of medical services
38. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: A valid diagnostic entity?
39. Long-term follow-up of generalized anxiety disorder
40. Natural course of anxiety disorders
41. Generalized anxiety disorder vs. panic disorder: Distinguishing characteristics and patterns of comorbidity
42. One year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age
43. Mental disorders and disability among patients in a primary care group practice
44. Psychiatric disorder onset and first treatment contact in the United States and Ontario
45. Recognition, management and outcome of psychological disorders in primary care: A naturalistic follow-up study
46. Common mental disorders and disability across cultures: Results from the WHO collaborative study on psychological problems in general health care
47. Distinguished mixed anxiety/depression from anxiety and depressive groups using the family history method
48. Family psychiatric histories in male patients with generalized anxiety disorder and major depressive disorder
49. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia
50. Comparing primary and secondary generalized anxiety disorder in a long-term naturalistic study of anxiety disorders
51. Generalized anxiety and mixed anxiety-depression: Association with disability and health care utilization
52. Pharmacologic treatment of generalized anxiety disorder in 1989 vs. 1996: Results from the Harvard/Brown Anxiety Disorders Research Program
53. The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder
54. Minor depression in a cohort of young adults in Israel
55. Health-related quality of life in primary care patients with mental disorders
56. The MOS short-form general health survey: Reliability and validity in a patient population
57. Recent care of common mental disorders in the United States: Prevalence and conformance with evidence-based recommendations
58. Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders
59. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey
60. Factors predicting the clinical course of generalised anxiety disorder
61. Phenomenology and course of generalized anxiety disorder